Fresenius SE & Co. KGaA (FSNUF)
OTCMKTS · Delayed Price · Currency is USD
55.90
+4.01 (7.73%)
At close: Dec 12, 2025
Fresenius SE & Co. KGaA Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $34.12 billion as of January 15, 2026. Its market cap has increased by 76.37% in one year.
Market Cap
34.12B
Enterprise Value
47.90B
Revenue
26.33B
Ranking
n/a
PE Ratio
25.44
Stock Price
$55.90
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 34.12B, an increase of 1,472.30%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 34.12B | 5.14% |
| Dec 30, 2025 | 32.45B | 65.57% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 807.56M |
| Glass House Brands | 742.36M |
| Elite Pharmaceuticals | 511.95M |
| Northwest Biotherapeutics | 446.23M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 338.88M |
| Silence Therapeutics | 277.26M |